Cargando…
New biomarkers in SLE: from bench to bedside
Biomarkers may have a diagnostic or monitoring value, or may predict response to therapy or disease course. The aim of this review is to discuss new serum and urinary biomarkers recently proposed for the diagnosis and management of SLE patients. Novel sensitive and specific assays have been proposed...
Autores principales: | Capecchi, Riccardo, Puxeddu, Ilaria, Pratesi, Federico, Migliorini, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719038/ https://www.ncbi.nlm.nih.gov/pubmed/32911542 http://dx.doi.org/10.1093/rheumatology/keaa484 |
Ejemplares similares
-
Liquid biopsy—from bench to bedside
por: Ray, Amitava, et al.
Publicado: (2022) -
Mediators of Inflammation and Angiogenesis in Chronic Spontaneous Urticaria: Are They Potential Biomarkers of the Disease?
por: Puxeddu, Ilaria, et al.
Publicado: (2017) -
Ig Glycosylation in Ulcerative Colitis: It’s Time for New Biomarkers
por: Capecchi, Riccardo, et al.
Publicado: (2021) -
Takotsubo Syndrome: From Bench to Bedside and Bedside to Bench
por: Pelliccia, Francesco, et al.
Publicado: (2022) -
CXCL12/SDF-1 in IgG4-Related Disease
por: Capecchi, Riccardo, et al.
Publicado: (2021)